Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Peter H, Sayre"'
Autor:
Charalambos Andreadis, Frank McCormick, Gabriela K. Fragiadakis, Pamela N. Munster, David P. Carbone, Chun J. Ye, Vivian Weinberg, Michael Flanders, Emma McMahon, Karin M. Gaensler, Peter H. Sayre, Thomas G. Martin, Lloyd E. Damon, Rebecca Olin, Gabriel N. Mannis, Matthew Settles, Aaron C. Logan, Tommy Jiang, Blythe Durbin-Johnson, Arjun A. Rao, Gregory K. Behbehani, Ravi K. Patel, Bradley W. Blaser, Victoria E. Wang
Supplementary Data from Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e9274c477d2ab2f5535764c6f7ffb71
https://doi.org/10.1158/2643-3230.22543692
https://doi.org/10.1158/2643-3230.22543692
Autor:
Charalambos Andreadis, Frank McCormick, Gabriela K. Fragiadakis, Pamela N. Munster, David P. Carbone, Chun J. Ye, Vivian Weinberg, Michael Flanders, Emma McMahon, Karin M. Gaensler, Peter H. Sayre, Thomas G. Martin, Lloyd E. Damon, Rebecca Olin, Gabriel N. Mannis, Matthew Settles, Aaron C. Logan, Tommy Jiang, Blythe Durbin-Johnson, Arjun A. Rao, Gregory K. Behbehani, Ravi K. Patel, Bradley W. Blaser, Victoria E. Wang
Acute myeloid leukemia (AML) patients refractory to induction therapy or relapsed within 1 year have poor outcomes. Autocrine production of hepatocyte growth factor by myeloid blasts drives leukemogenesis in preclinical models. A phase Ib trial evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c6723e49382eda7eadaaae9301736b6
https://doi.org/10.1158/2643-3230.c.6550365.v1
https://doi.org/10.1158/2643-3230.c.6550365.v1
Autor:
Sandy Feng, Michele DesMarais, Abraham Shaked, K. Rajender Reddy, Oren Shaked, Jeffrey D. Punch, Jack Demetris, Jorge Reyes, Peter H. Sayre, Goran B. Klintmalm, Whitney Jackson, Josh Levitsky, Bao-Li Loza
Publikováno v:
Transplantation
Transplantation, vol 106, iss 1
Transplantation, vol 106, iss 1
BackgroundDeceased donor and recipient predictors of posttransplant steatosis/steatohepatitis and fibrosis are not well known. Our aim was to evaluate the prevalence and assess donor and recipient predictors of steatosis, steatohepatitis, and fibrosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81328038386f72023f759b3198462dbc
https://pubmed.ncbi.nlm.nih.gov/33982909
https://pubmed.ncbi.nlm.nih.gov/33982909
Autor:
Jerry Lee, Raja Rajalingam, Denice Kong, Weiyun Ai, Charalambos B. Andreadis, Lloyd E. Damon, Neil Dunavin, Karin M. Gaensler, Lawrence D. Kaplan, Thomas G. Martin, Rebecca L. Olin, Peter H. Sayre, Catherine C. Smith, Jeffrey L. Wolf, Aaron C. Logan
Publikováno v:
Transplantation and Cellular Therapy. 29:S232-S233
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e1beee8a66231161eb70abc6b9a13ce
https://doi.org/10.1016/s2666-6367(23)00373-1
https://doi.org/10.1016/s2666-6367(23)00373-1
Autor:
Andrew H. Tam, Aaron C. Logan, Angela J. Choi, Richard Fong, Lloyd E. Damon, Rebecca L. Olin, Neil Dunavin, Peter H. Sayre, Karin L. Gaensler, Catherine Smith, Lily Yan
Publikováno v:
Blood. 140:4895-4896
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::314eed8731ea16f059c7970f5dae6137
https://doi.org/10.1182/blood-2022-164862
https://doi.org/10.1182/blood-2022-164862
Autor:
Irwin M. Feuerstein, Ji Hyun Lee, Nina M. Aiosa, Richard S. Bennett, Jennifer Sword, Dima A. Hammoud, Peter H. Sayre, Marcelo A. Castro, Syed M.S. Reza, Christopher Bartos, Dara Bradley, Michael R. Holbrook, Reed F. Johnson, Jeffrey Solomon
Publikováno v:
Int J Comput Assist Radiol Surg
PURPOSE: Certain viral infectious diseases cause systemic damage and the liver is an important organ affected directly by the virus and/or the hosts’ response to the virus. Medical imaging indicates that the liver damage is heterogenous, therefore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d55b82db1116efb1bfa25d6beccc0f7
https://doi.org/10.1007/s11548-020-02225-9
https://doi.org/10.1007/s11548-020-02225-9
Autor:
Karin M.L. Gaensler, Charalambos Andreadis, Ravi K. Patel, Michael Flanders, Chun Jimmie Ye, Arjun A. Rao, Rebecca L. Olin, Vivian Weinberg, Bradley W. Blaser, Tommy Jiang, Frank McCormick, David P. Carbone, Pamela N. Munster, Aaron C Logan, Victoria E. Wang, Gregory K. Behbehani, Lloyd E. Damon, Blythe Durbin-Johnson, Matthew L. Settles, Peter H. Sayre, Gabriel N. Mannis, Thomas G. Martin, Gabriela K. Fragiadakis, Emma McMahon
Publikováno v:
Blood Cancer Discov
Blood cancer discovery, vol 2, iss 5
Blood cancer discovery, vol 2, iss 5
Acute myeloid leukemia (AML) patients refractory to induction therapy or relapsed within 1 year have poor outcomes. Autocrine production of hepatocyte growth factor by myeloid blasts drives leukemogenesis in preclinical models. A phase Ib trial evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5af9f5ea3caf0d25186aa2f35c09bf3b
https://pubmed.ncbi.nlm.nih.gov/34514432
https://pubmed.ncbi.nlm.nih.gov/34514432
Autor:
Peter H. Sayre, Geoffrey L. Uy, Anjali S. Advani, Teia Curtis, Mojca Jongen-Lavrencic, Patrick J. Stiff, Patrick Kaminker, Jan K Davidson-Moncada, John Muth, Mary Beth Collins, Martha Arellano, Kuo Guo, Harry P. Erba, Martin Wermke, John E. Godwin, Ezio Bonvini, Ouiam Bakkacha, Kathy M. Tran, Erin Timmeny, Jennifer Seiler, Matteo Carrabba, Priyanka Patel, Jian Zhao, Fabio Ciceri, Max S. Topp, Roland B. Walter, Kenneth Jacobs, Ibrahim Aldoss, Christian Recher, G. Huls, Ashkan Emadi, Patrice Chevalier, Sergio Rutella, Emmanuel Gyan, Farhad Ravandi, Bob Löwenberg, Matthew J. Wieduwilt, Laura C. Michaelis, John F. DiPersio, Michael Byrne, Antonio Curti, Norbert Vey, Michael P. Rettig, Matthew C. Foster, Maya Kostova
Publikováno v:
Blood. 136:16-18
Introduction. Approximately 40% of patients (pts) with newly diagnosed AML either fail to achieve complete remission with intensive induction therapy or experience disease recurrence after a short remission (CR1 6 months), the probability of response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd5ec9689577ae8a31c0cf30d24bb69b
https://doi.org/10.1182/blood-2020-134576
https://doi.org/10.1182/blood-2020-134576
Autor:
Norbert Vey, Michael P. Rettig, John Muth, Leo Luznik, Matthew C. Foster, Ivana Gojo, Ashkan Emadi, Harry P. Erba, Ibrahim Aldoss, Martha Arellano, Farhad Ravandi, Roland B. Walter, Max S. Topp, Jayakumar Vadakekolathu, Michael Byrne, Bob Löwenberg, Patrick J. Stiff, Sergio Rutella, Christian Recher, Laura C. Michaelis, John F. DiPersio, Matthew J. Wieduwilt, Antonio Curti, Mojca Jongen-Lavrencic, Matteo Carrabba, Martin Wermke, Patrick Kaminker, Fabio Ciceri, Peter H. Sayre, Anjali S. Advani, Sarah E. Church, Emmanuel Gyan, Tung On Yau, G. Huls, Jan K Davidson-Moncada, John E. Godwin, Geoffrey L. Uy, Patrice Chevalier
Publikováno v:
Blood. 136:26-28
We have recently shown that bone marrow (BM) RNA profiles stratify patients with acute myeloid leukemia (AML) into immune-infiltrated and immune-depleted subtypes and that type I/II interferon (IFN)-related gene signatures associate with complete res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ceb9091f0d8851143a1ba5a5d670e21b
https://doi.org/10.1182/blood-2020-134921
https://doi.org/10.1182/blood-2020-134921
Autor:
Martha Arellano, Peter H. Sayre, Anjali S. Advani, Bob Löwenberg, Ibrahim Aldoss, Mary Beth Collins, Norbert Vey, Jian Zhao, Kuo Guo, Michael P. Rettig, Matthew C. Foster, John F. DiPersio, Antonio Curti, Maya Kostova, Sergio Rutella, Kenneth Jacobs, Ezio Bonvini, Stephanie Christ, Roland B. Walter, Fabio Ciceri, Patrick Kaminker, G. Huls, Ouiam Bakkacha, Martin Wermke, John Muth, Priyanka Patel, Farhad Ravandi, Laura C. Michaelis, Matteo Carrabba, Max S. Topp, Michael Byrne, Harry P. Erba, Mojca Jongen-Lavrencic, Matthew J. Wieduwilt, Erin Timmeny, Kathy M. Tran, Ashkan Emadi, Emmanuel Gyan, Jan K Davidson-Moncada, Jennifer Seiler, John E. Godwin, Patrice Chevalier, Teia Curtis, Geoffrey L. Uy, Christian Recher, Patrick J. Stiff
Publikováno v:
Blood. 136:19-21
Introduction: CRS is a potentially life-threatening toxicity observed following T cell-redirecting therapies. CRS is associated with elevated cytokines, including IL6, IFNγ, TNFα, IL2 and GM-CSF. Glucocorticosteroids (GC) and the IL6 receptor block
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ddd19a6292964248b4fe14f160e5c2fe
https://doi.org/10.1182/blood-2020-134612
https://doi.org/10.1182/blood-2020-134612